Source: GlobalNewswire

Press Release: Intellia : Intellia Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - NTLA

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Intellia Therapeutics, Inc. ("Intellia" or the "Company") (NASDAQ: NTLA) of a class action securities lawsuit.

Read full article »
Annual Revenue
$25-100M
Employees
250-500
John Leonard's photo - President & CEO of Intellia

President & CEO

John Leonard

CEO Approval Rating

82/100

Read more